BankInvest Biomedical Venture - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $95,863.59 -0.46%
Ethereum $3,475.11 +4.84%
BNB $648.38 -0.24%
Optimism $2.32 +10.43%
Arbitrum $0.92 +12.75%
Solana $242.81 -1.62%
Polygon $0.58 +7.24%
Cosmos $8.19 -0.74%
Avalanche $43.06 +8.93%

Bitcoin $95,863.59 -0.46%
Ethereum $3,475.11 +4.84%
BNB $648.38 -0.24%
Optimism $2.32 +10.43%
Arbitrum $0.92 +12.75%
Solana $242.81 -1.62%
Polygon $0.58 +7.24%
Cosmos $8.19 -0.74%
Avalanche $43.06 +8.93%

BankInvest Biomedical Venture

investment firm

Summary
Investments
Exits

About

BankInvest Biomedical Venture makes investments in research-based biotechnology companies in Europe.

Highlights

Lead Investments

Details

Founded date: Jan 1, 1998
Operating Status: Active
Investor Type: Venture Capital

Investments

Number of Investments

Number of Lead Investments

9

3

BankInvest Biomedical Venture has made 9 investments. Their most recent investment was on Aug 18, 2008, when F2G raised £6.30M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Aug 18, 2008 F2G	Series Unknown	£6.30M	Biotechnology	Yes
Aug 9, 2007 Nereus Pharmaceuticals	Series D	$45M	Biotechnology	Yes
Sep 26, 2006 Resistentia Pharmaceuticals	Series C	$13.96M	Biotechnology	—
Jun 1, 2005 Cellectis	Series C	€5.60M	Biopharma	—
Mar 1, 2005 LiPlasome Pharma	Series B	$8.01M	Biotechnology	—

Show More

Exits

BankInvest Biomedical Venture has had 3 exits. BankInvest Biomedical Venture most notable exits include Genmab , Cellectis

Date	Company Name	Exit Type	Industry
Jul 17, 2019	Genmab	IPO	Biotechnology	Detail
Apr 17, 2015	Cellectis	IPO	Biopharma	Detail
Jan 1, 2012	Nereus Pharmaceuticals	M&A	Biotechnology	Detail